A Study Measuring and Tracking Changes in Overactive Bladder (OAB) Medication

Astellas

Status: Withdrawn

Conditions: Overactive Bladder (OAB)

Study type: Observational

Funder types: Industry

Identifiers

NCT01317810

905-UC-060

Details and patient eligibility

About

The purpose of this study is to track changes in overactive bladder (OAB) medical regimen and/or OAB medication dosage requirements.

Full description

Subjects will complete a study specific survey questionnaire at Screening and the Month 1 through Month 6 visits. Subjects will be followed for 6 months.

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Subject has overactive bladder as determined by their prescribing physician
• Subject is currently receiving pharmacotherapy for overactive bladder
• Subject is willing to comply with required protocol/study requirements

Exclusion criteria

• Subject has a history of a clinically significant illness or medical condition prior to screening that would preclude participation in the study
• Male subjects with Lower Urinary Tract Symptoms (LUTS) or Bladder Outlet Obstruction (BOO)

Trial design

0 participants in 1 patient group

Subjects with Overactive Bladder (OAB)

Description:

Combination of new OAB subjects and existing subjects on OAB medication